Cumberland Pharmaceuticals (CPIX) Net Cash Flow (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Net Cash Flow of -$437448.0 for Q1 2026, up 88.34% sequentially from -$3.8 million in Q4 2025, and up 84.68% YoY from -$236865.6 in Q1 2025.
Cumberland Pharmaceuticals (CPIX) Net Cash Flow (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Net Cash Flow for 17 years, with the latest figure at -$437448.0 in Q1 2026.
- Quarterly Net Cash Flow rose 84.68% year-over-year to -$437448.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.1 million (down 19.22% YoY) and the FY2025 annual result came in at -$6.5 million, down 1723.94% from the prior year.
- Net Cash Flow grew to -$437448.0 in Q1 2026 per CPIX's latest filing, from -$3.8 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $1.9 million in Q2 2023 and troughed at -$9.8 million in Q1 2022.
- A 5-year average of -$943151.2 and a median of $128308.0 in 2024 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2022 and 2024: Net Cash Flow plunged 5879.04% in 2022, then jumped 368.02% in 2024.
- Over 5 years, Net Cash Flow stood at $216432.0 in 2022, then slumped by 186.1% to -$186341.0 in 2023, then surged by 368.02% to $499430.0 in 2024, then plunged by 851.27% to -$3.8 million in 2025, then soared by 88.34% to -$437448.0 in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered -$437448.0, -$3.8 million, and -$890536.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 114.68 Mn | 110.82 Mn | - | -11.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11.20 Mn |
| Jun 30, 2026 | -11.20 Mn |
| Mar 31, 2026 | -437,448.00 |
| Mar 31, 2026 | -437,448.00 |
| Dec 31, 2025 | -3.75 Mn |
| Dec 31, 2025 | -3.75 Mn |
| Sep 30, 2025 | -890,536.00 |
| Sep 30, 2025 | -890,536.00 |
| Jun 30, 2025 | 978,868.00 |
| Jun 30, 2025 | 978,868.00 |
| Mar 31, 2025 | -2.86 Mn |
| Mar 31, 2025 | -2.86 Mn |
| Dec 31, 2024 | 499,430.00 |
| Dec 31, 2024 | 499,430.00 |
| Sep 30, 2024 | 128,308.00 |
| Sep 30, 2024 | 128,308.00 |
| Jun 30, 2024 | -1.21 Mn |
| Jun 30, 2024 | -1.21 Mn |
| Mar 31, 2024 | 226,861.00 |
| Mar 31, 2024 | 226,861.00 |